Privi Speciality Chemicals Limited · NSE:PRIVISCL
Privi Speciality Chemicals — Q1 FY2025-26 Earnings Presentation
16 slides from Privi Speciality Chemicals's earnings presentation, Aug 5, 2025
Slide 1: Letter to BSE and NSE on Investors Presentation
4- August Q5, 2025 The Manager (CRD) The Manager - Listing Department The BSE Limited National Stock Exchange of lndia Ltd Phiroze Jeejee bhoy Towers, Exchange Plaza, Plot no.Cl1,, G Block, Dalal Street, Fort, Bandra-Kurla Complex, Bandra (East) Mumbai- 400001 Mumbai- 400 05L Scrip Code: 530117 Symb
Slide 2: Privi Speciality Chemicals Limited Investor Presentation - Q1 FY25-26
Privi Speciality Chemicals Limited Investor Presentation - Q1 FY25-26
Slide 3: Safe Harbor
Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Privi Speciality Chemicals Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe fo
Slide 4: From the CMD's Desk
From the CMD’s Desk We are pleased to begin FY26 on a steady note, with continued momentum across our key products. This quarter marks the beginning of a transformative phase for Privi, as we lay the foundation for a more integrated, resilient, and future-ready organization. All our key products con
Slide 5: Summary of Progress
Summary of Progress Improved asset management, Robust demand across particularly working capital all product categories leading to steadily improving return on capital – ROCE, ROE Capacity Augmentation –Phase 1 of Continued focus on the expansion is partly completed and sustainability – will start c
Slide 6: Q1 FY 25-26 Financial Performance
Q1 FY 25-26 Financial Performance Revenue (Rs Cr) EBITDA (Rs Cr) Margin 21.7% 20.8% 25.2% 24.8% Standalone Consolidated Standalone Consolidated 144.7 141.1 574.7 567.8 466.7 443.4 96.2 97.1 Q1 FY24-25 Q1 FY25-26 Q1 FY24-25 Q1 FY25-26 Financial Highlights • Standalone Revenue from operations for Q1 F
Slide 7: Q1 FY 25-26 Financial Performance
Q1 FY 25-26 Financial Performance PAT (Rs Cr) ROE and ROCE (%) Margin 7.3% 6.7% 12.0% 10.9% ROE ROCE Standalone Consolidated 68.7 19.6% 61.9 18.2% 12.9% 32.2 13.2% 31.4 Q1 FY24-25 Q1 FY25-26 Q1 FY24-25 Q1 FY25-26 Financial Highlights • Standalone PAT for Q1 FY25-26 grew 113.3% compared to Q1 FY24-25
Slide 8: Standalone Q1 FY25-26 Profit and Loss
Standalone Q1 FY25-26 Profit and Loss Particulars (Rs. Cr) Q1 FY25-26 Q1 FY24-25 % change FY24-25 FY23-24 % change Revenue from Operations 566.4 441.2 2,038.3 1,712.1 Other Income 8.3 2.2 17.9 21.6 Total Income 574.7 443.4 29.6% 2,056.2 1,733.7 18.6% Cost of materials consumed 289.8 244.1 1,105.6 98
Slide 9: Consolidated Q1 FY25-26 Profit and Loss
Consolidated Q1 FY25-26 Profit and Loss Particulars (Rs. Cr) Q1 FY25-26 Q1 FY24-25 % change FY24-25 FY23-24 % change Revenue from Operations 558.8 464.0 2,101.2 1,752.2 Other Income 9.0 2.7 20.6 26.3 Total Income 567.8 466.7 21.7% 2,121.8 1,778.5 19.3% Cost of materials consumed 275.2 260.6 1,131.5
Slide 10: Steady Growth in Annual Performance (Consolidated)
Steady Growth in Annual Performance (Consolidated) Revenue (Rs. In Cr) EBITDA (Rs. In Cr) EBITDA Margin (%) PAT (Rs. In Cr) 1.31% 5.37% 8.71% Margin +14% 2,121.84 1,778.53 22.35% 1,629.24 +51% 474.16 19.95% 184.75 +194.7% 354.82 12.73% 95.43 207.34 21.28 FY23 FY24 FY25 FY23 FY24 FY25 FY23 FY24 FY25
Slide 11: Levers to the Financial Performance
Levers to the Financial Performance 10
Slide 12: Sustainability
Sustainability Top 1% globally in Environment, Labor, Ethics & Sustainable Procurement Recognized for Responsible chemical manufacturing Validated by International Clients and Supply Chains Highest possible certification provided by Ecovadis - World’s most trusted sustainability rating Aligned with
Slide 13: Demand Outlook: Trends and Features
Demand Outlook : Trends and Features Emerging Trends Industry Features Surge in Niche Fragrance Requirements High R&D Intensity Demand for personalized, artisanal scents tailored to specific identities Innovation-led, with constant pressure to deliver novel and safe and occasions. olfactory molecule
Slide 14: Proposed Scheme of Amalgamation
Proposed Scheme of Amalgamation Amalgamation of Privi Fine Sciences Private Limited and Privi Biotechnologies Limited with Privi Speciality Chemicals Limited Privi Fine Sciences Privi Biotechnologies Privi Speciality Private Limited (PFSPL) Private Limited (PBPL) Chemicals Limited (PSCL) • Incorpora
Slide 15: Operational Excellence: Driving Efficiency, Quality & Sustainability
Operational Excellence : Driving Efficiency, Quality & Sustainability Safety & People-First Sustainability Asset & Capacity Process Efficiency R&D and Quality Culture Integration Optimization • Regular safety audits and • About 70% raw materials • Continuous process • 2 R&D centers (Mahad & • Capaci
Slide 16: Thank You!
Thank You ! Company: Privi Speciality Chemicals Ltd. CIN – L15140MH1985PLC286828 Mr. Narayan S. Iyer – Chief Financial Officer Email – investors@privi.co.in www.privi.com Investor Relations Advisor : Strategic Growth Advisors Pvt. Ltd. CIN - U74140MH2010PTC204285 Mr. Shrikant Sangani / Ms. Shaily Pa
Privi Speciality Chemicals — Q1 FY2025-26 Earnings Presentation on 6ix